SCHEDULE 13D/A: Zeo Scientifix CEO/CFO Ian Bothwell Consolidates Significant Voting Power, Reaching 40.8% Stake

Ian T. Bothwell, Interim CEO and CFO of Zeo Scientifix, Inc., has significantly increased his beneficial ownership and aggregate voting power in the company to 40.8% through recent acquisitions of warrants, options, and Series C Preferred Stock.

Summary

• Ian T. Bothwell, the Interim Chief Executive Officer, Chief Financial Officer, and a director of Zeo Scientifix, Inc., has filed an Amendment No. 2 to his Schedule 13D, updating his beneficial ownership.
• Mr. Bothwell now beneficially owns 1,052,594 shares of common stock, which includes 187,500 shares issuable upon exercise of warrants and 125,000 shares issuable upon exercise of options.
• This common stock holding represents 15.3% of the voting power, based on 6,582,419 shares of common stock outstanding as of September 13, 2024.
• Additionally, Mr. Bothwell holds 50 shares of Series C Preferred Stock, which grants him an additional 25.5% of the total voting power.
• His aggregate voting power in Zeo Scientifix, Inc. now stands at 40.8%.
• The additional shares were acquired through warrants for 150,000 common shares issued on August 19, 2022, in consideration for waiving accrued but unpaid compensation, options for 125,000 common shares granted on July 11, 2024, under the company's 2021 Equity Incentive Plan, and 50 shares of Series C Preferred Stock transferred on December 30, 2024, without further consideration.
• The reported share numbers reflect adjustments due to a 200-for-one reverse stock split implemented effective November 28, 2023.
• Mr. Bothwell has no definite plans to acquire or dispose of additional shares but may do so in the future, subject to compliance with regulations.

Sentiment

Score: 6

Explanation: The document is primarily a factual disclosure of increased insider ownership and voting power. While increased insider stake can be seen positively, the concentration of voting power could also be viewed with caution from a governance perspective. It does not contain performance results.

Positives

• Increased insider ownership by the Interim CEO/CFO and Director, potentially signaling strong confidence in the company's future.
• The waiver of accrued but unpaid compensation by the CEO/CFO in exchange for warrants indicates a commitment to the company's financial health and a willingness to align personal compensation with equity performance.

Risks

• The significant concentration of voting power (40.8%) in a single individual, Ian T. Bothwell, could raise corporate governance concerns regarding shareholder influence and potential for unilateral decision-making.
• Future share acquisitions or dispositions by the Reporting Person could impact market perception and share price volatility.

Future Outlook

The Reporting Person has no definite plan to acquire or dispose of additional shares of the Issuer's common stock in open market or private transactions, but explicitly states he may do so in the future. Similarly, while there is no definite plan to issue additional shares to the Reporting Person under equity incentive plans, the board or a committee may determine to issue such awards from time to time.

Management Comments

• Ian T. Bothwell, as the Reporting Person, has indicated that he has no definite plan to acquire or dispose of additional shares of the Issuer's common stock in open market or private transactions, but reserves the right to do so in the future.
• The Reporting Person's acceptance of warrants in consideration for waiving accrued but unpaid compensation demonstrates a commitment to the company's financial position and a preference for equity-based incentives.

Industry Context

This Schedule 13D filing is a disclosure of a change in beneficial ownership by an insider and does not provide information directly related to broader industry trends or competitive landscape. It primarily reflects an internal corporate governance and ownership structure update.

Corporate Governance

Legal Proceedings

• The Reporting Person, Ian T. Bothwell, has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
• The Reporting Person was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws during the last five years.

Related Party Transactions

• On August 19, 2022, warrants to purchase 150,000 shares of common stock were issued to Ian T. Bothwell in consideration of his agreement to waive payment of certain accrued but unpaid compensation due to him as of July 31, 2022, pursuant to his employment agreement with the Issuer.

Stakeholder Impact

• Shareholders: The significant increase in voting power by the Interim CEO/CFO could lead to more centralized decision-making, potentially impacting the influence of other shareholders on corporate matters.
• Management/Employees: The equity awards (warrants and options) granted to the CEO/CFO align his interests more closely with the company's performance and shareholder value.

Next Steps

• Potential future acquisitions or dispositions of Zeo Scientifix, Inc. common stock by Ian T. Bothwell.
• Potential future issuance of equity awards to Ian T. Bothwell under the Issuer's equity incentive plans, as determined by the board of directors or a committee.

Key Dates

Keywords

Zeo Scientifix, SEC filing, Schedule 13D, beneficial ownership, voting power, common stock, preferred stock, Ian T. Bothwell, CEO, CFO, stock options, warrants, insider ownership, corporate governance